117 related articles for article (PubMed ID: 1693371)
1. Current trends in the management of Graves' disease.
Solomon B; Glinoer D; Lagasse R; Wartofsky L
J Clin Endocrinol Metab; 1990 Jun; 70(6):1518-24. PubMed ID: 1693371
[TBL] [Abstract][Full Text] [Related]
2. The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association.
Nagayama Y; Izumi M; Nagataki S
Endocrinol Jpn; 1989 Apr; 36(2):299-314. PubMed ID: 2476301
[TBL] [Abstract][Full Text] [Related]
3. The management of Graves' disease by Indian thyroidologists.
Mithal A; Shah A; Kumar S
Natl Med J India; 1993; 6(4):163-6. PubMed ID: 7691310
[TBL] [Abstract][Full Text] [Related]
4. Differences and similarities in the treatment of diffuse goiter in Europe and the United States.
Wartofsky L; Glinoer D; Solomon B; Lagasse R
Exp Clin Endocrinol; 1991 May; 97(2-3):243-51. PubMed ID: 1717298
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
[TBL] [Abstract][Full Text] [Related]
6. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
7. Case selection and restrictions recommended to patients with hyperthyroidism in South America.
Romaldini JH
Thyroid; 1997 Apr; 7(2):225-8. PubMed ID: 9133690
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
Véliz J; Pineda G; Arancibia P; Wohllk N
Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
[TBL] [Abstract][Full Text] [Related]
9. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
[TBL] [Abstract][Full Text] [Related]
10. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
Wartofsky L; Glinoer D; Solomon B; Nagataki S; Lagasse R; Nagayama Y; Izumi M
Thyroid; 1991; 1(2):129-35. PubMed ID: 1688014
[TBL] [Abstract][Full Text] [Related]
11. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.
Berg GE; Michanek AM; Holmberg EC; Fink M
J Nucl Med; 1996 Feb; 37(2):228-32. PubMed ID: 8667049
[TBL] [Abstract][Full Text] [Related]
12. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
14. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Basedow-Graves' hyperthyroidism: retrospective analysis after 30 years].
Pineda G; Arancibia P; Mejía G
Rev Med Chil; 1998 Aug; 126(8):953-62. PubMed ID: 9830747
[TBL] [Abstract][Full Text] [Related]
16. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
17. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
[TBL] [Abstract][Full Text] [Related]
18. A 2013 survey of clinical practice patterns in the management of primary hypothyroidism.
Burch HB; Burman KD; Cooper DS; Hennessey JV
J Clin Endocrinol Metab; 2014 Jun; 99(6):2077-85. PubMed ID: 24527720
[TBL] [Abstract][Full Text] [Related]
19. The management of Graves' disease in New Zealand: results of a national survey.
Ford HC; Delahunt JW; Feek CM
N Z Med J; 1991 Jun; 104(914):251-2. PubMed ID: 2057150
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
